BARD1 and ovarian cancer: Moreover, several DEmiRNAs, such as miR-141 and miR-210, have been proven to control oxidative stress responses in ovarian cancer cells and endometriotic cells by targeting p38α and BARD1, respectively [67, 68], suggesting that several identified DEmiRNAs may function as modulators in response to oxidative stress.